课题基金 / 基金详情

D-amino acids as modulators of the genotoxic polyketide, colibactin.

D-amino acids as modulators of the genotoxic polyketide, colibactin.
D-氨基酸作为基因毒性聚酮化合物大肠杆菌素的调节剂。
批准号:
BB/W015781/1
负责人:
Andrew Roe
金额:
$61.11万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2023
资助国家:
英国
项目状态:
未结题
起止时间:
2023 至 --

项目摘要

项目成果

Andrew Roe的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
"You are what you eat" is a commonly used phrase that everyone should take on board. For example, information from over 4 million patients has shown that obesity, type 2 diabetes, and poor metabolic health are three significant risk factors for worse COVID-19 outcomes. These risk factors are heavily influenced by the food we eat. The challenge is that our diet is complex and it can be hard to know what is "good" or "bad" for you. Moreover, there is an increasing appreciation of the importance of our "gut health", the complex mix of different microbes that help us break down food and protect against harmful bacteria. Many people try and supplement their gut microbes with so called "good bacteria" or probiotics that claim to provide, and in some cases are even shown, to have clear positive impacts. But do we know these probiotics are actually safe? Recent work has shown that strains of E. coli that have been used for almost 100 years as probiotics, can actually produce a toxin that induces colo-rectal cancer. This is really worrying for us. For example, bowel cancer is the 3rd most common cancer (10% of all new female cancer cases/ 13% of all new male cancer cases) in the UK and highly related to diet. By chance, we have found a simple supplement that helps reduce the production of the toxin made by E. coli when it is grown in the lab. We now have 3 important questions: (1) can we make even more effective supplements to block the toxin. (2) how does the supplement affect toxin production and (3) can it work in animals? These are the three aims of this work. In addition, our work also aims to understand if the supplement itself affects the normal bacteria within the gut. We will test this by looking at the different species that live in the gut before and after the treatment. This is key to knowing that the treatment itself does not cause problems.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
A new twist on drug design: AdhE spirosomes as cross species anti-virulence targets
  • 批准号:
    BB/V009494/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $63.51万
  • 财政年份:
    2021
  • 负责人:
    Andrew Roe
  • 依托单位:
Aversion Therapy for Bacteria: Repurposing Aurodox
  • 批准号:
    MR/V011499/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $79.06万
  • 财政年份:
    2021
  • 负责人:
    Andrew Roe
  • 依托单位:
The Role of Dietary D-serine in Health and Disease
  • 批准号:
    BB/R006539/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $75.47万
  • 财政年份:
    2018
  • 负责人:
    Andrew Roe
  • 依托单位:
Where and Why: The Influence of Host Metabolism on Bacterial Niche Specificity
  • 批准号:
    BB/M029646/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $56.07万
  • 财政年份:
    2016
  • 负责人:
    Andrew Roe
  • 依托单位:
国内基金
海外基金
衰老上皮细胞FABP4调控HSDL2致脂肪酸代谢失衡在BPH发病中的机制研究
  • 批准号:
    82370774
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    阮渊
  • 依托单位:
具有抗癌活性的天然产物金霉酸(Aureolic acids)全合成与选择性构建2-脱氧糖苷键
  • 批准号:
    22007039
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2020
  • 负责人:
    王黎明
  • 依托单位:
海洋放线菌来源聚酮类化合物Pteridic acids生物合成机制研究
手性Lewis Acids催化的分子内串联1,5-氢迁移/环合反应及其在构建结构多样性手性含氮杂环化合物中的应用